Study Stopped
Investigator closed study-no accrual
Local Heat-Stress as a Mechanism of Hearing Preservation
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
This pilot study plans to determine whether or not local heat-stress as a mechanism can help to preserve hearing in adults treated with Cisplatin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2016
CompletedFirst Posted
Study publicly available on registry
August 19, 2016
CompletedStudy Start
First participant enrolled
November 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2018
CompletedAugust 22, 2023
August 1, 2023
2.1 years
August 16, 2016
August 17, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Audiometric Effect
Audiometric evaluation will serve as the primary measure of outcome.
One year
Study Arms (1)
Heat-stress
EXPERIMENTALEach participant will undergo a 30-minute heat stress to one randomized ear. The participant will be reclined and the hot air caloric at 50°C applied by a licensed, unblinded audiologist for 30 minutes.
Interventions
Each patient will undergo a 30-minute heat stress to one ear. For randomization, the left ear will be treated in patients with a registration number ending with an odd number and the right for even numbers. An ICS AirCal3 Research Strategy (Otometrics) system attached to an Intel Core 15vPro Thinkpad (IBM) laptop is used within the audiometry department of a separate outpatient clinic. The patients will be reclined and the hot air caloric at 50°C applied by a licensed, unblinded audiologist for 30 minutes. The patients will be allowed to fixate and use whatever means they prefer for entertainment during the intervention.
Eligibility Criteria
You may qualify if:
- Any patient undergoing total cisplatin in total doses \> 100mg/m2.
- Written consent.
- Age \> 19 years.
You may not qualify if:
- Inability to tolerate the intervention
- Exposure to cisplatin treatment without intervention.
- Head and neck carcinoma
- Baseline asymmetric hearing loss.
- Pregnant or breastfeeding women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Judge, MD
University of Nebraska
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2016
First Posted
August 19, 2016
Study Start
November 3, 2016
Primary Completion
December 13, 2018
Study Completion
December 13, 2018
Last Updated
August 22, 2023
Record last verified: 2023-08